Reduced bronchoalveolar macrophage phagocytosis and cytotoxic effects after controlled short-term exposure to wood smoke in healthy humans.

Air pollution Biomass combustion Bronchoscopy Controlled human exposure Cytotoxicity In vitro Macrophages Phagocytosis Wood smoke

Journal

Particle and fibre toxicology
ISSN: 1743-8977
Titre abrégé: Part Fibre Toxicol
Pays: England
ID NLM: 101236354

Informations de publication

Date de publication:
31 07 2023
Historique:
received: 17 02 2023
accepted: 13 07 2023
medline: 1 8 2023
pubmed: 31 7 2023
entrez: 30 7 2023
Statut: epublish

Résumé

Exposure to wood smoke has been shown to contribute to adverse respiratory health effects including airway infections, but the underlying mechanisms are unclear. A preceding study failed to confirm any acute inflammation or cell influx in bronchial wash (BW) or bronchoalveolar lavage (BAL) 24 h after wood smoke exposure but showed unexpected reductions in leukocyte numbers. The present study was performed to investigate responses at an earlier phase, regarding potential development of acute inflammation, as well as indications of cytotoxicity. In a double-blind, randomised crossover study, 14 healthy participants were exposed for 2 h to filtered air and diluted wood smoke from incomplete wood log combustion in a common wood stove with a mean particulate matter concentration of 409 µg/m Exposure to wood smoke increased BAL lactate dehydrogenase (LDH) (p = 0.04) and reduced the ex vivo alveolar macrophage phagocytic capacity (p = 0.03) and viability (p = 0.02) vs. filtered air. BAL eosinophil numbers were increased after wood smoke (p = 0.02), while other cell types were unaffected in BW and BAL. In vitro exposure to wood smoke particles confirmed increased DNA-damage, decreased metabolic activity and cell cycle disturbances. Exposure to wood smoke from incomplete combustion did not induce any acute airway inflammatory cell influx at 6 h, apart from eosinophils. However, there were indications of a cytotoxic reaction with increased LDH, reduced cell viability and impaired alveolar macrophage phagocytic capacity. These findings are in accordance with earlier bronchoscopy findings at 24 h and may provide evidence for the increased susceptibility to infections by biomass smoke exposure, reported in population-based studies.

Sections du résumé

BACKGROUND
Exposure to wood smoke has been shown to contribute to adverse respiratory health effects including airway infections, but the underlying mechanisms are unclear. A preceding study failed to confirm any acute inflammation or cell influx in bronchial wash (BW) or bronchoalveolar lavage (BAL) 24 h after wood smoke exposure but showed unexpected reductions in leukocyte numbers. The present study was performed to investigate responses at an earlier phase, regarding potential development of acute inflammation, as well as indications of cytotoxicity.
METHODS
In a double-blind, randomised crossover study, 14 healthy participants were exposed for 2 h to filtered air and diluted wood smoke from incomplete wood log combustion in a common wood stove with a mean particulate matter concentration of 409 µg/m
RESULTS
Exposure to wood smoke increased BAL lactate dehydrogenase (LDH) (p = 0.04) and reduced the ex vivo alveolar macrophage phagocytic capacity (p = 0.03) and viability (p = 0.02) vs. filtered air. BAL eosinophil numbers were increased after wood smoke (p = 0.02), while other cell types were unaffected in BW and BAL. In vitro exposure to wood smoke particles confirmed increased DNA-damage, decreased metabolic activity and cell cycle disturbances.
CONCLUSIONS
Exposure to wood smoke from incomplete combustion did not induce any acute airway inflammatory cell influx at 6 h, apart from eosinophils. However, there were indications of a cytotoxic reaction with increased LDH, reduced cell viability and impaired alveolar macrophage phagocytic capacity. These findings are in accordance with earlier bronchoscopy findings at 24 h and may provide evidence for the increased susceptibility to infections by biomass smoke exposure, reported in population-based studies.

Identifiants

pubmed: 37517998
doi: 10.1186/s12989-023-00541-x
pii: 10.1186/s12989-023-00541-x
pmc: PMC10388518
doi:

Substances chimiques

Smoke 0
DNA 9007-49-2

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

30

Informations de copyright

© 2023. The Author(s).

Références

Eur Respir J. 2019 Feb 28;53(2):
pubmed: 30578387
Eur Respir J. 2006 Feb;27(2):359-65
pubmed: 16452593
Am J Respir Crit Care Med. 2000 Jul;162(1):161-6
pubmed: 10903236
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Ann Glob Health. 2015 May-Jun;81(3):368-74
pubmed: 26615071
Am J Respir Cell Mol Biol. 2002 Jul;27(1):34-41
pubmed: 12091243
J Appl Toxicol. 2019 Aug;39(8):1143-1154
pubmed: 30957912
Ann Allergy Asthma Immunol. 2003 Oct;91(4):346-53
pubmed: 14582813
Chem Res Toxicol. 2011 Feb 18;24(2):168-84
pubmed: 21235221
Glob Health Action. 2012 Sep 05;5:1-13
pubmed: 22989509
Lancet. 2001 Aug 25;358(9282):619-24
pubmed: 11530148
J Aerosol Med Pulm Drug Deliv. 2015 Aug;28(4):237-46
pubmed: 25393443
Carcinogenesis. 2005 Mar;26(3):613-20
pubmed: 15591089
Cold Spring Harb Protoc. 2018 Jun 1;2018(6):
pubmed: 29858337
Toxicol Sci. 2018 Jul 1;164(1):21-30
pubmed: 29534242
Part Fibre Toxicol. 2020 Jun 15;17(1):27
pubmed: 32539833
Front Med (Lausanne). 2018 Nov 13;5:309
pubmed: 30483506
Am J Respir Cell Mol Biol. 2015 May;52(5):584-93
pubmed: 25254931
Hum Exp Toxicol. 2006 Oct;25(10):559-79
pubmed: 17165623
Am J Respir Crit Care Med. 1999 Mar;159(3):702-9
pubmed: 10051240
J Immunol. 2022 Jan 1;208(1):110-120
pubmed: 34819391
Toxicol Sci. 2009 May;109(1):113-23
pubmed: 19293371
J Appl Toxicol. 2013 Apr;33(4):281-9
pubmed: 22131134
Part Fibre Toxicol. 2013 Jun 06;10:20
pubmed: 23742058
Occup Environ Med. 2008 May;65(5):319-24
pubmed: 17704195
Inhal Toxicol. 2012 Jan;24(1):47-59
pubmed: 22220980
Curr Opin Allergy Clin Immunol. 2012 Feb;12(1):82-90
pubmed: 22157154
Am J Respir Crit Care Med. 2001 Sep 1;164(5):826-30
pubmed: 11549540
Toxics. 2017 Dec 01;5(4):
pubmed: 29194400
Respir Med. 2002 May;96(5):352-8
pubmed: 12113386
Part Fibre Toxicol. 2015 Oct 29;12:33
pubmed: 26511835
Occup Environ Med. 1999 Aug;56(8):527-34
pubmed: 10492649
Clin Sci (Lond). 2008 Sep;115(6):175-87
pubmed: 18691154
Part Fibre Toxicol. 2009 Nov 06;6:29
pubmed: 19891791
Part Fibre Toxicol. 2012 Nov 23;9:45
pubmed: 23176191
J Toxicol Environ Health A. 2017;80(13-15):596-604
pubmed: 28524757
Trans R Soc Trop Med Hyg. 2008 Sep;102(9):843-51
pubmed: 18639310
Bull World Health Organ. 2008 May;86(5):390-398C
pubmed: 18545742
Mutat Res. 2008 Jul 3;642(1-2):37-42
pubmed: 18495177
Part Fibre Toxicol. 2020 Oct 2;17(1):49
pubmed: 33008417
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
Part Fibre Toxicol. 2012 Mar 27;9:7
pubmed: 22452928
Inhal Toxicol. 2010 Dec;22(14):1144-50
pubmed: 21110774
Occup Environ Med. 2012 Mar;69(3):170-5
pubmed: 21719562
Int J Environ Res Public Health. 2021 Jun 29;18(13):
pubmed: 34209476
Adv Drug Deliv Rev. 2013 Dec;65(15):2087-97
pubmed: 23751779
Part Fibre Toxicol. 2010 Aug 20;7:21
pubmed: 20727160
Lancet. 2014 May 3;383(9928):1581-92
pubmed: 24792855
Lancet Glob Health. 2020 Nov;8(11):e1427-e1434
pubmed: 33069303
Environ Toxicol. 2017 May;32(5):1487-1499
pubmed: 27678477
Eur Respir J. 2015 Dec;46(6):1577-88
pubmed: 26405285

Auteurs

Alva Hansson (A)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden. alva.hansson@umu.se.

Gregory Rankin (G)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Oskari Uski (O)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Maria Friberg (M)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Jamshid Pourazar (J)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Robert Lindgren (R)

Thermochemical Energy Conversion Laboratory, Department of Applied Physics and Electronics, Umeå University, Umeå, Sweden.

Natxo García-López (N)

Thermochemical Energy Conversion Laboratory, Department of Applied Physics and Electronics, Umeå University, Umeå, Sweden.

Christoffer Boman (C)

Thermochemical Energy Conversion Laboratory, Department of Applied Physics and Electronics, Umeå University, Umeå, Sweden.

Thomas Sandström (T)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Annelie Behndig (A)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Ala Muala (A)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH